Figure 3
Distribution of H-scores as measured by IHC, grouped according to patient response (clinical benefit=CR; PR; s.d.â©Ÿ24 weeks; no clinical benefit=s.d. <24 weeks; PD; NE). (A) IGF1R protein expression levels (n=58; P=0.3394). (B) PTEN protein expression levels (n=36; P=0.9093).
